Search
Patexia Research
Case number 1:21-cv-01408

Neurocrine Biosciences, Inc. v. Lupin Limited et al > Summary

Court Case Number 1:21-cv-01408

Filing Date Oct 1, 2021

Termination Date Nov 13, 2023

Court Delaware District Court

Status Dismissed - Other

JudgesMaryellen Noreika

Plaintiff

Neurocrine Biosciences

Defendant

3

Lupin Atlantis Holdings Sa

Lupin Pharmaceuticals

Lupin Limited

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
11040029 Methods for the administration of certain VMAT2 inhibitors Jun 22, 2021
11026931 Methods for the administration of certain VMAT2 inhibitors Jun 8, 2021
11026939 High dosage valbenazine formulation and compositions, methods, and kits related thereto Jun 8, 2021
10993941 Methods for the administration of certain VMAT2 inhibitors May 4, 2021
10952997 Methods for the administration of certain VMAT2 inhibitors Mar 23, 2021
10940141 Methods for the administration of certain VMAT2 inhibitors Mar 9, 2021
10919892 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 16, 2021
10912771 Methods for the administration of certain VMAT2 inhibitors Feb 9, 2021
10906902 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 2, 2021
10906903 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 2, 2021
Menu